Added 1 day ago Drug news

Phase III OPTIC study of PTK 0796 shows high response rate in community-acquired bacterial pneumonia.- Paratek Pharma.

Paratek Pharmaceuticals presented an analysis of data from the Company’s Phase III OPTIC study of PTK 0796 (omadacycline) vs. moxifloxacin...

Added 1 day ago Drug news

Multiple studies of Vibativ in real world settings for infections in obese or elderly patients.- Theravance BioPharma

Theravance Biopharma, Inc.announced that positive new data from multiple studies of Vibativ (telavancin) were presented at the 28th European Congress...

Added 4 days ago Drug news

Phase III studies initiated for PVC 15 vaccine for prevention of pneumococcal disease.- Merck inc.

Merck announced that the company is beginning two Phase III studies of PCV 15 (V114), its investigational polyvalent conjugate vaccine...

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 2 years ago

Safety guideline: skin antisepsis for central neuraxial blockade

Concise guidelines are presented that recommend the method of choice for skin antisepsis before central neuraxial blockade. The Working Party...

Added 3 years ago

United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014

The main objective is to assist practitioners in managing men and women diagnosed with Trichomonas vaginalis. This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principle...

Added 3 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 2 months ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 11 months ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 11 months ago